Efficacy of Low-Dose Trimethoprim/Sulfamethoxazole for the Treatment of Pneumocystis jirovecii Pneumonia in Deceased Donor Kidney Recipients
Jianlei Ji,* Qinghai Wang,* Tao Huang, Ziyu Wang, Pingli He, Chen Guo, Weijia Xu, Yanwei Cao, Zhen Dong, Hongyang Wang Department of Kidney Transplantation, the Affiliated Hospital of Qingdao University, Qingdao, 266000, People’s Republic of China*These authors contributed eq...
Guardado en:
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Dove Medical Press
2021
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/06d8e487541341dca1cc49e9da012931 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:06d8e487541341dca1cc49e9da012931 |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:06d8e487541341dca1cc49e9da0129312021-11-23T18:43:01ZEfficacy of Low-Dose Trimethoprim/Sulfamethoxazole for the Treatment of Pneumocystis jirovecii Pneumonia in Deceased Donor Kidney Recipients1178-6973https://doaj.org/article/06d8e487541341dca1cc49e9da0129312021-11-01T00:00:00Zhttps://www.dovepress.com/efficacy-of-low-dose-trimethoprimsulfamethoxazole-for-the-treatment-of-peer-reviewed-fulltext-article-IDRhttps://doaj.org/toc/1178-6973Jianlei Ji,* Qinghai Wang,* Tao Huang, Ziyu Wang, Pingli He, Chen Guo, Weijia Xu, Yanwei Cao, Zhen Dong, Hongyang Wang Department of Kidney Transplantation, the Affiliated Hospital of Qingdao University, Qingdao, 266000, People’s Republic of China*These authors contributed equally to this workCorrespondence: Zhen Dong; Hongyang WangDepartment of Kidney Transplantation, the Affiliated Hospital of Qingdao University, No. 59 Haier Road, Qingdao, 266000, People’s Republic of ChinaTel +8613455263336; +8618661803752Email dong266000@163.com; why19850804@163.comBackground: Trimethoprim/sulfamethoxazole (TMP-SMX) is considered the first-choice treatment for Pneumocystis jirovecii pneumonia (PJP) in recipients of solid organ transplantation. However, this treatment is associated with various severe adverse events that might not be tolerable for some renal transplant recipients, and the optimal dose remains elusive. The present study assessed the efficacy of low-dose TMP-SMX in recipients of a deceased donor kidney.Methods: A total of 37 adult deceased donor kidney recipients who suffered PJP between January 2015 and June 2020 were included. The survival rates of the patients and grafts, the rate of invasive ventilation, and adverse events, including gastrointestinal discomfort, hematologic side effects, hyperkalemia, and renal function impairments, were assessed.Results: The patient and graft survival rates were both 100%. Two patients (5.4%) required invasive ventilation. Eight patients (21.6%) reported gastrointestinal discomfort, but none required dose reduction or discontinued treatment. The frequencies of hematologic side effects, hyperkalemia and impaired kidney function were 5.4% (2/37), 2.7% (1/37), and 2.7% (1/37), respectively.Conclusion: Optimization of TMP-SMX dose may reduce the risk of adverse events without compromising efficacy for the treatment of PJP in deceased donor kidney recipients.Keywords: efficacy, low dose, trimethoprim/sulfamethoxazole, Pneumocystis jirovecii pneumonia, deceased donor kidney recipientsJi JWang QHuang TWang ZHe PGuo CXu WCao YDong ZWang HDove Medical Pressarticleefficacylow dosetrimethoprim/sulfamethoxazolepneumocystis jirovecii pneumoniadeceased donor kidney recipientsInfectious and parasitic diseasesRC109-216ENInfection and Drug Resistance, Vol Volume 14, Pp 4913-4920 (2021) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
efficacy low dose trimethoprim/sulfamethoxazole pneumocystis jirovecii pneumonia deceased donor kidney recipients Infectious and parasitic diseases RC109-216 |
| spellingShingle |
efficacy low dose trimethoprim/sulfamethoxazole pneumocystis jirovecii pneumonia deceased donor kidney recipients Infectious and parasitic diseases RC109-216 Ji J Wang Q Huang T Wang Z He P Guo C Xu W Cao Y Dong Z Wang H Efficacy of Low-Dose Trimethoprim/Sulfamethoxazole for the Treatment of Pneumocystis jirovecii Pneumonia in Deceased Donor Kidney Recipients |
| description |
Jianlei Ji,* Qinghai Wang,* Tao Huang, Ziyu Wang, Pingli He, Chen Guo, Weijia Xu, Yanwei Cao, Zhen Dong, Hongyang Wang Department of Kidney Transplantation, the Affiliated Hospital of Qingdao University, Qingdao, 266000, People’s Republic of China*These authors contributed equally to this workCorrespondence: Zhen Dong; Hongyang WangDepartment of Kidney Transplantation, the Affiliated Hospital of Qingdao University, No. 59 Haier Road, Qingdao, 266000, People’s Republic of ChinaTel +8613455263336; +8618661803752Email dong266000@163.com; why19850804@163.comBackground: Trimethoprim/sulfamethoxazole (TMP-SMX) is considered the first-choice treatment for Pneumocystis jirovecii pneumonia (PJP) in recipients of solid organ transplantation. However, this treatment is associated with various severe adverse events that might not be tolerable for some renal transplant recipients, and the optimal dose remains elusive. The present study assessed the efficacy of low-dose TMP-SMX in recipients of a deceased donor kidney.Methods: A total of 37 adult deceased donor kidney recipients who suffered PJP between January 2015 and June 2020 were included. The survival rates of the patients and grafts, the rate of invasive ventilation, and adverse events, including gastrointestinal discomfort, hematologic side effects, hyperkalemia, and renal function impairments, were assessed.Results: The patient and graft survival rates were both 100%. Two patients (5.4%) required invasive ventilation. Eight patients (21.6%) reported gastrointestinal discomfort, but none required dose reduction or discontinued treatment. The frequencies of hematologic side effects, hyperkalemia and impaired kidney function were 5.4% (2/37), 2.7% (1/37), and 2.7% (1/37), respectively.Conclusion: Optimization of TMP-SMX dose may reduce the risk of adverse events without compromising efficacy for the treatment of PJP in deceased donor kidney recipients.Keywords: efficacy, low dose, trimethoprim/sulfamethoxazole, Pneumocystis jirovecii pneumonia, deceased donor kidney recipients |
| format |
article |
| author |
Ji J Wang Q Huang T Wang Z He P Guo C Xu W Cao Y Dong Z Wang H |
| author_facet |
Ji J Wang Q Huang T Wang Z He P Guo C Xu W Cao Y Dong Z Wang H |
| author_sort |
Ji J |
| title |
Efficacy of Low-Dose Trimethoprim/Sulfamethoxazole for the Treatment of Pneumocystis jirovecii Pneumonia in Deceased Donor Kidney Recipients |
| title_short |
Efficacy of Low-Dose Trimethoprim/Sulfamethoxazole for the Treatment of Pneumocystis jirovecii Pneumonia in Deceased Donor Kidney Recipients |
| title_full |
Efficacy of Low-Dose Trimethoprim/Sulfamethoxazole for the Treatment of Pneumocystis jirovecii Pneumonia in Deceased Donor Kidney Recipients |
| title_fullStr |
Efficacy of Low-Dose Trimethoprim/Sulfamethoxazole for the Treatment of Pneumocystis jirovecii Pneumonia in Deceased Donor Kidney Recipients |
| title_full_unstemmed |
Efficacy of Low-Dose Trimethoprim/Sulfamethoxazole for the Treatment of Pneumocystis jirovecii Pneumonia in Deceased Donor Kidney Recipients |
| title_sort |
efficacy of low-dose trimethoprim/sulfamethoxazole for the treatment of pneumocystis jirovecii pneumonia in deceased donor kidney recipients |
| publisher |
Dove Medical Press |
| publishDate |
2021 |
| url |
https://doaj.org/article/06d8e487541341dca1cc49e9da012931 |
| work_keys_str_mv |
AT jij efficacyoflowdosetrimethoprimsulfamethoxazoleforthetreatmentofpneumocystisjiroveciipneumoniaindeceaseddonorkidneyrecipients AT wangq efficacyoflowdosetrimethoprimsulfamethoxazoleforthetreatmentofpneumocystisjiroveciipneumoniaindeceaseddonorkidneyrecipients AT huangt efficacyoflowdosetrimethoprimsulfamethoxazoleforthetreatmentofpneumocystisjiroveciipneumoniaindeceaseddonorkidneyrecipients AT wangz efficacyoflowdosetrimethoprimsulfamethoxazoleforthetreatmentofpneumocystisjiroveciipneumoniaindeceaseddonorkidneyrecipients AT hep efficacyoflowdosetrimethoprimsulfamethoxazoleforthetreatmentofpneumocystisjiroveciipneumoniaindeceaseddonorkidneyrecipients AT guoc efficacyoflowdosetrimethoprimsulfamethoxazoleforthetreatmentofpneumocystisjiroveciipneumoniaindeceaseddonorkidneyrecipients AT xuw efficacyoflowdosetrimethoprimsulfamethoxazoleforthetreatmentofpneumocystisjiroveciipneumoniaindeceaseddonorkidneyrecipients AT caoy efficacyoflowdosetrimethoprimsulfamethoxazoleforthetreatmentofpneumocystisjiroveciipneumoniaindeceaseddonorkidneyrecipients AT dongz efficacyoflowdosetrimethoprimsulfamethoxazoleforthetreatmentofpneumocystisjiroveciipneumoniaindeceaseddonorkidneyrecipients AT wangh efficacyoflowdosetrimethoprimsulfamethoxazoleforthetreatmentofpneumocystisjiroveciipneumoniaindeceaseddonorkidneyrecipients |
| _version_ |
1718416133322702848 |